Drug-resistant gonorrhoea is a growing threat: a South African case study

  06 November 2020

Gonorrhoea is a sexually transmitted infection caused by a bacterium called Neisseria gonorrhoeae. This infection affects 87 million  people every year across the world. It can lead to genital discharge, pregnancy complications and infertility. Gonorrhoea can be treated successfully with antibiotics.

Current first-line treatment is a ceftriaxone injection combined with azithromycin given as oral tablet. But in recent years, alarming reports emerged of these drugs failing to treat gonorrhoea patients. Drug-resistance has been reported in Asia, Europe and Australia.

 

Further reading: The Conversation
Author(s): The Conversation
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed